Quantitative benefit-risk tradeoff preferences for Crohn’s Disease treatments: Implications for regulatory decision making and disease management
Johnson, F., Hauber, A., Ozdemir, S., Siegel, CA., Sands, BE., & Hass, S. (2009). Quantitative benefit-risk tradeoff preferences for Crohn’s Disease treatments: Implications for regulatory decision making and disease management. International Journal of Medical and Biological Frontiers, 15(5/6), 457-466.
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.